Power Corp of Canada’s ResMed RMD Stock Holding History

Power Corp of Canada’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,170	Closed	-$3.47M	–	130
2023 Q4	$3.47M	Hold	20,170	–	–	0.36%	102
2023 Q3	$2.98M	Hold	20,170	–	–	0.19%	94
2023 Q2	$4.41M	Sell	20,170 -997	-5%	-$222K	0.44%	76
2023 Q1	$4.5M	Buy	21,167 +11,068	+110%	+$2.4M	0.46%	72
2022 Q4	$2.1M	Hold	10,099	–	–	0.38%	69
2022 Q3	$2.21M	Buy	+10,099	New	+$2.3M	0.51%	57
2022 Q2	–	Sell	-6,536	Closed	-$1.58M	–	168
2022 Q1	$1.58M	Buy	+6,536	New	+$1.58M	0.13%	99

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Power Corp of Canada's RMD Position: Q1 2024 in Review

Power Corp of Canada sold out of ResMed (RMD) in Q1 2024, closing a stake of 20,170 shares — an estimated $3.47M sold.

Power Corp of Canada first reported a position in RMD in Q1 2022 and held it in 7 quarters. The position peaked at $4.5M in Q1 2023. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Power Corp of Canada reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
Power Corp of Canada sold 20,170 ResMed shares in Q1 2024, an estimated $3.47M.
Power Corp of Canada first reported a position in ResMed in Q1 2022 and held it in 7 quarters.
Power Corp of Canada's ResMed position peaked at $4.5M in Q1 2023.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Power Corp of Canada's 13F filing for Q1 2024, filed 14 May 2024.